Patents by Inventor Philip Manton Brown

Philip Manton Brown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160022718
    Abstract: Methods of improving the cardiovascular and/or metabolic health of patients, particularly those suffering from type 2 diabetes, are disclosed, as well as compounds and pharmaceutical compositions useful therein.
    Type: Application
    Filed: October 6, 2015
    Publication date: January 28, 2016
    Inventors: Philip Manton Brown, Joel Philip Freiman, David Reed Powell
  • Publication number: 20150374686
    Abstract: A method of treating flushing associated with carcinoid tumors and carcinoid syndrome in a patient in need thereof comprising topically applying a pharmaceutical composition comprising an effective amount of an alpha adrenergic receptor agonist, pharmaceutically acceptable salt thereof, or combinations thereof; and a pharmaceutically acceptable carrier to the site of the flushing is claimed.
    Type: Application
    Filed: June 24, 2015
    Publication date: December 31, 2015
    Inventor: Philip Manton Brown
  • Publication number: 20140018308
    Abstract: Methods of improving the cardiovascular and/or metabolic health of patients, particularly those suffering from type 2 diabetes, are disclosed, as well as compounds and pharmaceutical compositions useful therein.
    Type: Application
    Filed: June 10, 2013
    Publication date: January 16, 2014
    Inventors: Philip Manton Brown, Joel Philip Freiman, David Reed Powell
  • Publication number: 20120077831
    Abstract: Methods of treating irritable bowel syndrome (IBS) are disclosed. Assays and kits useful in the treatment of IBS are also disclosed.
    Type: Application
    Filed: July 28, 2011
    Publication date: March 29, 2012
    Inventor: Philip Manton Brown
  • Patent number: 8093291
    Abstract: Methods and compositions comprising tryptophan hydroxylase inhibitors are disclosed. Particular methods are directed at reducing or avoiding serotonin-mediated adverse effects associated with some drugs.
    Type: Grant
    Filed: June 24, 2008
    Date of Patent: January 10, 2012
    Assignee: Lexicon Pharmaceuticals, Inc.
    Inventors: Philip Manton Brown, Qingyun Liu
  • Publication number: 20110263601
    Abstract: Methods are disclosed for treating ulcerative colitis and related diseases and disorders, which comprise inhibiting tryptophan hydroxylase (TPH) in patients in need thereof.
    Type: Application
    Filed: October 25, 2010
    Publication date: October 27, 2011
    Inventors: Philip Manton Brown, Qingyun Liu, Brian Zambrowicz
  • Publication number: 20110218159
    Abstract: Methods of improving the cardiovascular and/or metabolic health of patients, particularly those suffering from type 2 diabetes, are disclosed, as well as compounds and pharmaceutical compositions useful therein.
    Type: Application
    Filed: March 1, 2011
    Publication date: September 8, 2011
    Inventors: Philip Manton Brown, Joel Philip Freiman, David Reed Powell
  • Publication number: 20110124667
    Abstract: Methods of treating irritable bowel syndrome (IBS) are disclosed. Assays and kits useful in the treatment of IBS are also disclosed.
    Type: Application
    Filed: November 19, 2010
    Publication date: May 26, 2011
    Inventor: Philip Manton BROWN
  • Publication number: 20100113530
    Abstract: Methods and compositions for treating, managing, and/or preventing cerebral malaria are disclosed.
    Type: Application
    Filed: October 29, 2009
    Publication date: May 6, 2010
    Inventors: Philip Manton Brown, Constance Ann Marjory Finney, Kevin Charles Kain, Tamas Oravecz, Stephen Chris Pappas
  • Publication number: 20090005381
    Abstract: Methods are disclosed for treating serotonin-mediated diseases and disorders, which comprise inhibiting tryptophan hydroxylase (TPH) in patients in need thereof.
    Type: Application
    Filed: June 24, 2008
    Publication date: January 1, 2009
    Inventors: Philip Manton Brown, Qingyun Liu, Brian Zambrowicz
  • Publication number: 20090005382
    Abstract: Methods and compositions comprising tryptophan hydroxylase inhibitors are disclosed. Particular methods are directed at reducing or avoiding serotonin-mediated adverse effects associated with some drugs.
    Type: Application
    Filed: June 24, 2008
    Publication date: January 1, 2009
    Inventors: Philip Manton Brown, Qingyun Liu